REFERENCES
- Kibbler CC, Manuel RJ. The epidemiology and prevention of invasive aspergillosis. J Hosp Infect. 1998;39:95–109.
- Chanock SJ, Walsh TJ. Evolving concepts of prevention and treatment of invasive fungal infections in paediatric bone marrow transplant recipients. Bone Marrow Transpl. 1996;18(Suppl 3):S15—S20.
- Denning DW. Treatment of invasive aspergillosis. pi/fat 1994;28:25–33.
- Hann IM, Stevens RF, Goldstone AH, et al. Randomised comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML 10). Adult and childhood leukemia working parties of the Medical Research Council. Blood. 1997;89:2311–2318.
- Anarita C, Barbara G, et al. FLAG: an effective and tolerable protocol for the treatment of poor risk acute myeloid leukemias. Leukemia. 1994;8:1842–1846.
- Allen C, Joseph A, Jorge M, Stephen C. Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Ann Int Med. 1979;90:4–9.
- Cheymol G., Porier JM. Prevention of aspergillosis with itraconazole in neutropenic patients. Bull Acad Natl Med. 1999;183:371–380.
- Kennedy HF, Michie JR, Richardson MD, Simpson EM, Wilson N. Aspergillus Jlavus endocarditis in a child with neuroblastoma. J Infect 1998;36:126–127.